HeyJaredOctavia Feliciano
- Indexed articles, last 90 days
- 20
- Latest publication
- Sep 29, 2026
- Outlet visibility, for Healio
- Top 500K sites
- Earliest in this view
- Jul 16, 2026
Latest articles
Xenobiotic-related liver injuries nearly quadrupled, driven largely by acetaminophen (opens the original)
Read excerpt
Cases of xenobiotic-induced liver injury have surged nearly fourfold since 2000, according to results of a retrospective study published in Clinical Gastroenterology and Hepatology. Among exogenous substances that can cause liver injury â including alcohol, environmental toxins, dietary supplements, illicit drugs and medications â acetaminophen was the most significant xenobiotic contributor over more than 2 decades. âMost national surveillance of xenobiotic-induced liver injury has focuse
Clinical vs. preclinical obesity distinction may aid risk assessment in bariatric surgery (opens the original)
Read excerpt
New Lancet Diabetes and Endocrinology Commission criteria, which distinguish clinical obesity from preclinical obesity, may better inform patient selection and risk assessment for bariatric surgery than BMI, analysis showed. Nearly 75% of surgical candidates met criteria for clinical obesity â defined as excess adiposity with obesity-related organ dysfunction â which was associated with greater preoperative disease burden and higher perioperative risk. âBecause this risk doesnât track wi
Patients with IBD report âmeaningful benefitsâ in symptom relief with marijuana use (opens the original)
Read excerpt
Patients with inflammatory bowel disease who used marijuana reported symptom relief, improved daily functioning and reduced opioid analgesic use, survey results showed. Prior research indicates some patients with IBD use marijuana to manage disease symptoms or treatment-related adverse events. âMarijuana use is prevalent for symptom control among patients with IBD and is rising with legalization; however, it is often not discussed in clinic visits,â Naueen A. Chaudhry, MD, assistant professo
Blood test targets âAchillesâ heelâ of CRC screening, detects 81% of advanced adenomas (opens the original)
Read excerpt
Researchers have developed a blood-based assay that could help identify individuals with precursor lesions for colorectal cancer, a known limitation of many blood-based screening tests. The assay, known as DENEB, detected 81% of advanced adenomas, as well as 91% of CRC overall and 92% of stage I to III cancers. Screening rates among adults at average risk for CRC in the U.S. often fall short of the proposed 80% benchmark for population-level impact, according to study background. Blood-based tes
GLP-1 users can have âterrific resultsâ with bariatric surgery to lose additional weight (opens the original)
Read excerpt
Preoperative GLP-1 receptor agonist use did not impact bariatric surgery outcomes, including weight loss at 1 year, diabetes control and postsurgical complications, according to a research letter published in JAMA Surgery. GLP-1s have become an integral part of obesity care, but clinicians still have questions about how pharmacologic therapy and surgical intervention interact. âSince the most effective treatment for obesity remains bariatric surgery, many have wondered how best to combine bari
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 500K sites
For Healio, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.